- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RaQualia Pharma Inc (4579)
RaQualia Pharma Inc stock price live, this page displays TYO 4579 stock exchange data. View the 4579 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the RaQualia Pharma Inc real time stock price chart below.
What Is the RaQualia Pharma Inc Stock Price Today?
The RaQualia Pharma Inc stock price today is 569.0.
What Is the Stock Symbol for RaQualia Pharma Inc?
The stock symbol for RaQualia Pharma Inc is ""4579.""
What Stock Exchange Does RaQualia Pharma Inc Trade On?
RaQualia Pharma Inc is listed and trades on the Tokyo stock exchange.
Is RaQualia Pharma Inc a Good Stock to Buy?
Determining whether RaQualia Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4579 quote. (ISIN: JP3967150008)
What Is the RaQualia Pharma Inc Stock Price Today?
The RaQualia Pharma Inc stock price today is 569.0.
What Is the Stock Symbol for RaQualia Pharma Inc?
The stock symbol for RaQualia Pharma Inc is ""4579.""
What Stock Exchange Does RaQualia Pharma Inc Trade On?
RaQualia Pharma Inc is listed and trades on the Tokyo stock exchange.
Is RaQualia Pharma Inc a Good Stock to Buy?
Determining whether RaQualia Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4579 quote. (ISIN: JP3967150008)
Tokyo
Currency in JPY
569.0
-13.0(-2.23%)
Closed·
Fair Value
An estimate of a RaQualia Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
569.0
587.0
52 wk Range
301.0
728.0
4579 Scorecard
Full Analysis
Liquid assets exceed short term obligations
4579 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a RaQualia Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
569.0587.0
52 wk Range
301.0728.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4579 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a RaQualia Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
RaQualia Pharma Inc Company Profile
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease; and grapiprant for cancer and pain management; RQ-00000008 for the treatment of osteoarthritis autoimmune disorders; RQ-00000010 to treat gastroparesis. The company also provides veterinary products, such as capromorelin to treat anorexia in dogs and weight management in cats; grapiprant for osteoarthritis in dogs; RQ-00000008 to treat osteoarthritis and others; RQ-00317076 for pain; and RQ-00000010 for gut motility disorders, gastroparesis, functional dyspepsia, and chronic constipation. In addition, it provides RQ-00433412 for constipation, and cancer-related anorexia/cachexia syndrome; RQ-00000009 to treat alzheimer's; RQ-00466479, RQ-00350215, and RQ-00434739 to treat chronic pain; RQ-00310941 to treat D-IBS, IBD-remission stage symptoms; RQ-00201894 for gastroparesis, functional dyspepsia, and post-operative ileus; tamibarotene to treat higher-risk myelodysplastic syndrome and acute myeloid leukemia; and FIM-001 for cancer. The company was incorporated in 2008 and is headquartered in Nagoya, Japan.
Compare 4579 to Peers and Sector
Metrics to compare | 4579 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4579PeersSector | |
|---|---|---|---|---|
P/E Ratio | −26.5x | 10.5x | −0.6x | |
PEG Ratio | −1.12 | 0.06 | 0.00 | |
Price/Book | 2.2x | 1.3x | 2.6x | |
Price / LTM Sales | 4.3x | 1.5x | 3.3x | |
Upside (Analyst Target) | 108.7% | −0.3% | 40.1% | |
Fair Value Upside | Unlock | 3.1% | 5.3% | Unlock |
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-15.25 / --
Revenue / Forecast
570.00M / --
People Also Watch
FAQ
What Stock Exchange Does RaQualia Pharma Trade On?
RaQualia Pharma is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for RaQualia Pharma?
The stock symbol for RaQualia Pharma is "4579."
What Is the RaQualia Pharma Market Cap?
As of today, RaQualia Pharma market cap is 13.99B.
What Is RaQualia Pharma's Earnings Per Share (TTM)?
The RaQualia Pharma EPS (TTM) is -23.60.
When Is the Next RaQualia Pharma Earnings Date?
RaQualia Pharma will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is 4579 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has RaQualia Pharma Stock Split?
RaQualia Pharma has split 0 times.
How Many Employees Does RaQualia Pharma Have?
RaQualia Pharma has 64 employees.
What is the current trading status of RaQualia Pharma (4579)?
As of 20 Aug 2025, RaQualia Pharma (4579) is trading at a price of 569.00, with a previous close of 582.00. The stock has fluctuated within a day range of 569.00 to 587.00, while its 52-week range spans from 301.00 to 728.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.